Description

The LAUREL study will look at the safety and effectiveness of an investigational, once-a-month injectable medication for people with moderately to severely active UC. The aim of the study is to look at the effect of the investigational medication in patients who are still experiencing symptoms of UC despite previous treatment with immunosuppressant medication(s).

Eligibility

Can I take part in the LAUREL study?

You may be eligible to take part in the LAUREL study if you are between 18 and 80 years of age (inclusive), and you:

  • Have been diagnosed with moderately to severely active UC
  • Have received treatment with immunosuppressant medication(s) for UC within the past five years, but still have symptoms
  • Do not have Crohn’s disease
  • Do not have an ileostomy or colostomy

During screening visits, study team members will conduct assessments to determine whether this study is suitable for you.

Contact

Guillermina Cruz Guillermina.Cruz@bcm.eduPhone 1: (713) 798-8220
IRB: h-37005

Status

Active

Created

May 06, 2016